Gene expression profiling of familial and sporadic interstitial pneumonia.

RATIONALE Idiopathic interstitial pneumonia (IIP) and its familial variants are progressive and largely untreatable disorders with poorly understood molecular mechanisms. Both the genetics and the histologic type of IIP play a role in the etiology and pathogenesis of interstitial lung disease, but transcriptional signatures of these subtypes are unknown. OBJECTIVES To evaluate gene expression in the lung tissue of patients with usual interstitial pneumonia or nonspecific interstitial pneumonia that was either familial or nonfamilial in origin, and to compare it with gene expression in normal lung parenchyma. METHODS We profiled RNA from the lungs of 16 patients with sporadic IIP, 10 with familial IIP, and 9 normal control subjects on a whole human genome oligonucleotide microarray. RESULTS Significant transcriptional differences exist in familial and sporadic IIPs. The genes distinguishing the genetic subtypes belong to the same functional categories as transcripts that distinguish IIP from normal samples. Relevant categories include chemokines and growth factors and their receptors, complement components, genes associated with cell proliferation and death, and genes in the Wnt pathway. The role of the chemokine CXCL12 in disease pathogenesis was confirmed in the murine bleomycin model of lung injury, with C57BL/6(CXCR4+/-) mice demonstrating significantly less collagen deposition than C57BL/6(CXCR4+/+) mice. Whereas substantial differences exist between familial and sporadic IIPs, we identified only minor gene expression changes between usual interstitial pneumonia and nonspecific interstitial pneumonia. CONCLUSIONS Taken together, our findings indicate that differences in gene expression profiles between familial and sporadic IIPs may provide clues to the etiology and pathogenesis of IIP.

[1]  V. M. Riccardi,et al.  Von Recklinghausen neurofibromatosis. , 1981, The New England journal of medicine.

[2]  W. Craig,et al.  A protective role for T lymphocytes in asbestos-induced pulmonary inflammation and collagen deposition. , 1994, American journal of respiratory cell and molecular biology.

[3]  D. Schwartz,et al.  Susceptibility to asbestos-induced and transforming growth factor-beta1-induced fibroproliferative lung disease in two strains of mice. , 2002, American journal of respiratory cell and molecular biology.

[4]  R. Crystal,et al.  Familial idiopathic pulmonary fibrosis. Evidence of lung inflammation in unaffected family members. , 1986, The New England journal of medicine.

[5]  M. Burdick,et al.  Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. , 2004, The Journal of clinical investigation.

[6]  Paul J. Friedman,et al.  American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors , 2002, American journal of respiratory and critical care medicine.

[7]  J. Kelsey,et al.  Idiopathic pulmonary fibrosis: challenges and opportunities for the clinician and investigator. , 2005, Chest.

[8]  P. Polakoff,et al.  PREVALENCE OF RADIOGRAPHIC ABNORMALITIES AMONG NORTHERN CALIFORNIA SHIPYARD WORKERS * , 1979, Annals of the New York Academy of Sciences.

[9]  R. Lilis,et al.  ASBESTOS DISEASE IN UNITED STATES SHIPYARDS * , 1979, Annals of the New York Academy of Sciences.

[10]  C. Martin,et al.  Involvement of the lungs in tuberous sclerosis. , 1970, Chest.

[11]  C. Carrington,et al.  Familial chronic interstitial pneumonia. , 2015, The American review of respiratory disease.

[12]  E. Hughes Familial Interstitial Pulmonary Fibrosis , 1964, Thorax.

[13]  V. Ferrans,et al.  Susceptibility to experimental interstitial lung disease is modified by immune- and non-immune-related genes. , 1987, The American review of respiratory disease.

[14]  Naftali Kaminski,et al.  Up-Regulation and Profibrotic Role of Osteopontin in Human Idiopathic Pulmonary Fibrosis , 2005, PLoS medicine.

[15]  R. Homer,et al.  Regulation of pulmonary fibrosis by chemokine receptor CXCR3. , 2004, The Journal of clinical investigation.

[16]  Jonathan Haines,et al.  Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. , 2002, American journal of respiratory and critical care medicine.

[17]  A. Nicholson,et al.  A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. , 1999, American journal of respiratory and critical care medicine.

[18]  G. Laurent,et al.  Pulmonary fibrosis: searching for model answers. , 2005, American journal of respiratory cell and molecular biology.

[19]  Naftali Kaminski,et al.  Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[20]  L. Mccormack,et al.  Familial Hamman-Rich syndrome. Report of eight cases. , 1969, Diseases of the chest.

[21]  J. Auwerx,et al.  Defective host defence mechanisms in a family with hypocalciuric hypercalcaemia and coexisting interstitial lung disease. , 1985, Clinical and experimental immunology.

[22]  N. Kaminski Microarray analysis of idiopathic pulmonary fibrosis. , 2003, American journal of respiratory cell and molecular biology.

[23]  R. Strawderman,et al.  Histopathologic variability in usual and nonspecific interstitial pneumonias. , 2001, American journal of respiratory and critical care medicine.

[24]  F. Green Overview of pulmonary fibrosis. , 2002, Chest.

[25]  U. Costabel,et al.  ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias , 2002, European Respiratory Journal.

[26]  Arnold Simanowitz,et al.  international consensus statement , 2000 .

[27]  S. Kunkel,et al.  Role of Eotaxin-1 (CCL11) and CC chemokine receptor 3 (CCR3) in bleomycin-induced lung injury and fibrosis. , 2005, The American journal of pathology.

[28]  C. Epstein,et al.  Severe pulmonary involvement in adult Gaucher's disease. Report of three cases and review of the literature. , 1977, The American journal of medicine.

[29]  H Page McAdams,et al.  Clinical and pathologic features of familial interstitial pneumonia. , 2005, American journal of respiratory and critical care medicine.

[30]  H. Clevers,et al.  WNT signalling and haematopoiesis: a WNT–WNT situation , 2005, Nature Reviews Immunology.

[31]  E. Hay,et al.  DIRECT EVIDENCE FOR A ROLE OF β‐CATENIN/LEF‐1 SIGNALING PATHWAY IN INDUCTION OF EMT , 2002, Cell biology international.

[32]  Naftali Kaminski,et al.  Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. , 2006, American journal of respiratory and critical care medicine.

[33]  V. Poletti,et al.  Aberrant Wnt/ (cid:1) -Catenin Pathway Activation in Idiopathic Pulmonary Fibrosis , 2003 .

[34]  M. Hallett,et al.  Murine candidate bleomycin induced pulmonary fibrosis susceptibility genes identified by gene expression and sequence analysis of linkage regions , 2005, Journal of Medical Genetics.

[35]  F. Martinez,et al.  Focal interstitial CC chemokine receptor 7 (CCR7) expression in idiopathic interstitial pneumonia , 2006, Journal of Clinical Pathology.

[36]  J. Enghild,et al.  Idiopathic Pulmonary Fibrosis , 2003 .

[37]  S. Phan,et al.  Bone marrow-derived progenitor cells in pulmonary fibrosis. , 2004, The Journal of clinical investigation.

[38]  Hideo Sakamoto,et al.  Inhibition of pulmonary fibrosis by the chemokine IP-10/CXCL10. , 2004, American journal of respiratory cell and molecular biology.

[39]  S. Javaheri,et al.  Idiopathic pulmonary fibrosis in monozygotic twins. The importance of genetic predisposition. , 1980, Chest.

[40]  M. Burdick,et al.  CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodeling. , 2005, American journal of respiratory and critical care medicine.

[41]  R. Terry,et al.  Adult lipidosis resembling Niemann-Pick's disease. , 1954, The American journal of pathology.

[42]  R. DePinho,et al.  The Hermansky–Pudlak Syndrome: REPORT OF THREE CASES AND REVIEW OF PATHOPHYSIOLOGY AND MANAGEMENT CONSIDERATIONS , 1985, Medicine.

[43]  David A. Lynch,et al.  Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement , 2000 .

[44]  A. Nicholson,et al.  The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. , 2000, American journal of respiratory and critical care medicine.

[45]  W. Banks,et al.  Expression of TNF and the necessity of TNF receptors in bleomycin-induced lung injury in mice. , 1998, Experimental lung research.

[46]  J. Frymoyer,et al.  A FAMILY STUDY OF IDIOPATHIC PULMONARY FIBROSIS. A POSSIBLE DYSPROTEINEMIC AND GENETICALLY DETERMINED DISEASE. , 1965, The American journal of medicine.